Celldex Therapeutics shares owned by Rafferty Asset Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Rafferty Asset Management
from 13F filings
Historical chart of Rafferty Asset Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Rafferty Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $8.0M | 191k | 41.97 |
| 2023-09-30 | $4.5M | 165k | 27.52 |
| 2023-06-30 | $7.0M | 206k | 33.93 |
| 2023-03-31 | $5.2M | 146k | 35.98 |
| 2022-12-31 | $6.4M | 143k | 44.57 |
| 2022-09-30 | $5.8M | 208k | 28.11 |
| 2022-06-30 | $3.3M | 124k | 26.96 |
| 2022-03-31 | $5.3M | 156k | 34.06 |
| 2021-12-31 | $5.6M | 144k | 38.64 |
| 2021-09-30 | $3.1M | 57k | 53.99 |
| 2021-06-30 | $2.6M | 79k | 33.44 |
| 2021-03-31 | $2.5M | 121k | 20.60 |
| 2020-12-31 | $452k | 26k | 17.53 |